Feifan Zhou1, Da Xing, Shengnan Wu, Wei R Chen. 1. MOE Key Laboratory of Laser Life Science and Institute of Laser Life Science, South China Normal University, Guangzhou, 510631, China.
Abstract
PURPOSE: The aim of the study is to dynamically and non-invasively monitor the apoptosis events in vivo during photodynamic therapy (PDT) and chemotherapy. PROCEDURES: A FRET probe, SCAT3, was utilized to determine activation of caspase-3 during tumor cell apoptosis in mice, induced by PDT, and cisplatin treatments. Using this method, dynamics of caspase-3 activation was observed both in vitro and in vivo. RESULTS: Analysis of the fluorescent missions from tumor cells indicated that the caspase-3 activation started immediately after PDT treatment. In contrast, the caspase-3 activation started about 13 and 36 h after cisplatin treatment in vitro and in vivo, respectively. CONCLUSIONS: FRET could be used effectively to monitor activation of caspase-3 in living organism. This method could be used to provide rapid assessment of apoptosis induced by anti-tumor therapies for improvement of treatment efficacy.
PURPOSE: The aim of the study is to dynamically and non-invasively monitor the apoptosis events in vivo during photodynamic therapy (PDT) and chemotherapy. PROCEDURES: A FRET probe, SCAT3, was utilized to determine activation of caspase-3 during tumor cell apoptosis in mice, induced by PDT, and cisplatin treatments. Using this method, dynamics of caspase-3 activation was observed both in vitro and in vivo. RESULTS: Analysis of the fluorescent missions from tumor cells indicated that the caspase-3 activation started immediately after PDT treatment. In contrast, the caspase-3 activation started about 13 and 36 h after cisplatin treatment in vitro and in vivo, respectively. CONCLUSIONS: FRET could be used effectively to monitor activation of caspase-3 in living organism. This method could be used to provide rapid assessment of apoptosis induced by anti-tumor therapies for improvement of treatment efficacy.
Authors: Bharathi Laxman; Daniel E Hall; Mahaveer Swaroop Bhojani; Daniel A Hamstra; Thomas L Chenevert; Brian D Ross; Alnawaz Rehemtulla Journal: Proc Natl Acad Sci U S A Date: 2002-12-10 Impact factor: 11.205
Authors: J L Evelhoch; R J Gillies; G S Karczmar; J A Koutcher; R J Maxwell; O Nalcioglu; N Raghunand; S M Ronen; B D Ross; H M Swartz Journal: Neoplasia Date: 2000 Jan-Apr Impact factor: 5.715
Authors: F G Blankenberg; P D Katsikis; R W Storrs; C Beaulieu; D Spielman; J Y Chen; L Naumovski; J F Tait Journal: Blood Date: 1997-05-15 Impact factor: 22.113
Authors: Vasilis Ntziachristos; Eyk A Schellenberger; Jorge Ripoll; Doreen Yessayan; Edward Graves; Alexei Bogdanov; Lee Josephson; Ralph Weissleder Journal: Proc Natl Acad Sci U S A Date: 2004-08-10 Impact factor: 11.205
Authors: James D Orth; Rainer H Kohler; Floris Foijer; Peter K Sorger; Ralph Weissleder; Timothy J Mitchison Journal: Cancer Res Date: 2011-06-28 Impact factor: 12.701